Search Results 81-90 of 8393 for TNF

  1. Arthritis Clinical Trials

    ... TNF alpha agents. A Study to Establish and Validate Standard Operating Procedures for Laboratory Tests on Synovial Fluid Rochester, MN. The purpose of this ...

  2. Defining the Immunologic Profile of Sentinel Lymph Nodes and Identifying the Mechanisms Responsible for Immunosuppression - Mayo Clinic

    TNF-inhibitors; Methotrexate; IL-1Ra antagonist. Women who are pregnant or nursing; Elect not to provide peripheral blood draw. Cohort 2: History of ipsilateral ...

  3. Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

    ... TNF-α apoptotic pathway, 2)alternative splicing, tipping the balance towards pro-apoptotic as opposed to anti-apoptotic isoforms, and 3)inhibition of the ...

  4. Juvenile idiopathic arthritis - Diagnosis and treatment - Mayo Clinic

    Also known as biologic response modifiers, this newer class of drugs includes tumor necrosis factor (TNF) blockers, such as etanercept (Enbrel, Erelzi ...

  5. Valley fever - Symptoms & causes - Mayo Clinic

    People with certain autoimmune diseases, such as rheumatoid arthritis or Crohn's disease, who are being treated with anti-tumor necrosis factor (TNF) drugs also ...

  6. Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 - Mayo Clinic

    ... TNF alpha agents. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

  7. A Study to Evaluate Response to Adalimumab in Rheumatoid Arthritis Patients - Mayo Clinic

    ... tumor necrosis factor receptor antagonist in adults with a clinical diagnosis of rheumatoid arthritis. Participation eligibility. Participant eligibility ...

  8. Publications - Francis A. Farraye, M.D., M.S. - Mayo Clinic

    Accelerating Earlier Access to Anti-TNF-alpha Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease. J Clin Med. 2025 Feb 26; 14 ...

  9. Safety and Immune Response of the COVID 19 Vaccine in Patients with Inflammatory Bowel Disease - Mayo Clinic

    Anti-TNF monotherapy;; anti-TNF combination therapy;; tofacitinib;; current use of systemic corticosteroids. Exclusion Criteria: Previously received COVID 19 ...

  10. A Study to Evaluate the Safety and Effectiveness of Ustekinumab as Initial or Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Is naïve to biologic therapy (TNF antagonists or vedolizumab); Has received biologic therapy but has not demonstrated a history of failure to respond to, or ...